Sai Life Sciences, one of India’s fastest growing contract development and manufacturing organizations (CDMOs), has added state-of-the-art cellular analysis platforms at its Discovery Biology facility in Cambridge, MA.   Coinciding with its first anniversary in Cambridge, the expanded suite of capabilities includes the Opera Phenix high content screening platform, FACSCelesta flow cytometer and FACSMelody flow sorter, enabling it to better serve start-up and biotech companies in the region...